Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Intra-Cellular Therapies Inc. - Common Stock (NQ:ITCI)

131.87 UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 131.87
Bid (Size) 131.90 (49)
Ask (Size) 131.92 (100)
Prev. Close 131.87
Today's Range 131.87 - 131.87
52wk Range 80.83 - 131.95
Shares Outstanding 94,324,313
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Mark Minervini may look into INTRA-CELLULAR THERAPIES INC (NASDAQ:ITCI)
A fundamental and technical analysis of (NASDAQ:ITCI): Why INTRA-CELLULAR THERAPIES INC (NASDAQ:ITCI) qualifies as a high growth stock. 
Via Chartmill
Demystifying Intra-Cellular Therapies: Insights From 6 Analyst Reviews
 
Via Benzinga

Performance

YTD
+56.5%
+56.5%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
+55.6%
+55.6%

More News

Read More
Stock Of The Day: Will Johnson & Johnson Rally? The Sell-Off May Have Ended
Via Benzinga
Evaluating INTRA-CELLULAR THERAPIES INC (NASDAQ:ITCI) using Mark Minervini’s winning stock formula
Via Chartmill
Johnson & Johnson Stops Late-Stage Depression Study Over 'Insufficient Efficacy'
Via Benzinga
Intra-Cellular Therapies Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Via Benzinga
Demystifying Intra-Cellular Therapies: Insights From 6 Analyst Reviews
Via Benzinga
INTRA-CELLULAR THERAPIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intra-Cellular Therapies, Inc. - ITCI
From Kahn Swick & Foti, LLC
Via Business Wire
ITCI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intra-cellular Therapies, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Nike To Rally Over 50%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
This Conagra Brands Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Via Benzinga
Axsome's AXS-05 In Alzheimer's Agitation Could Be Billion Dollar Opportunity, Says Analyst
Via Benzinga
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LGTY, ENFN, ITCI, SSTK on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Logility Supply Chain Solutions, Inc. (Nasdaq - LGTY), Enfusion, Inc. (NYSE - ENFN), Intra-Cellular Therapies, Inc. (Nasdaq - ITCI), Shutterstock, Inc. (NYSE - SSTK)
From Brodsky & Smith LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Logility Supply Chain Solutions, Inc. (Nasdaq - LGTY), Enfusion, Inc. (NYSE - ENFN), Intra-Cellular Therapies, Inc. (Nasdaq - ITCI), Shutterstock, Inc. (NYSE - SSTK)
From Brodsky & Smith LLC
Via GlobeNewswire
Johnson & Johnson Q4 Earnings: Cancer Drugs Performance Drives Revenue Beat, Issues Strong FY25 Outlook
Via Benzinga
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, ITCI, HEES, SSTK on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Enfusion, Inc. (NYSE - ENFN), Intra-Cellular Therapies, Inc. (Nasdaq - ITCI), H&E Equipment Services, Inc. (Nasdaq - HEES), Shutterstock, Inc. (NYSE - SSTK)
From Brodsky & Smith LLC
Via GlobeNewswire
Top 4 Health Care Stocks You May Want To Dump In Q1
Via Benzinga
MicroStrategy, SoFi Technologies And Carvana Are Among Top Large-Cap Gainers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
Via Benzinga
MarketBeat Week in Review – 01/13 - 01/17
Via MarketBeat
Topics Economy Energy
Stock Market Rises On Tame Inflation, Bank Earnings: Weekly Review
Via Investor's Business Daily
Topics Economy
Is Johnson & Johnson Stock Set to Reward Long-Term Holders?
Via MarketBeat
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, ITCI, EDBL on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
INTRA-CELLULAR THERAPIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intra-Cellular Therapies, Inc. - ITCI
From Kahn Swick & Foti, LLC
Via Business Wire

Frequently Asked Questions

Is Intra-Cellular Therapies Inc. - Common Stock publicly traded?
Yes, Intra-Cellular Therapies Inc. - Common Stock is publicly traded.
What exchange does Intra-Cellular Therapies Inc. - Common Stock trade on?
Intra-Cellular Therapies Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Intra-Cellular Therapies Inc. - Common Stock?
The ticker symbol for Intra-Cellular Therapies Inc. - Common Stock is ITCI on the Nasdaq Stock Market
What is the current price of Intra-Cellular Therapies Inc. - Common Stock?
The current price of Intra-Cellular Therapies Inc. - Common Stock is 131.87
When was Intra-Cellular Therapies Inc. - Common Stock last traded?
The last trade of Intra-Cellular Therapies Inc. - Common Stock was at 04/01/25 04:00 PM ET
What is the market capitalization of Intra-Cellular Therapies Inc. - Common Stock?
The market capitalization of Intra-Cellular Therapies Inc. - Common Stock is 12.44B
How many shares of Intra-Cellular Therapies Inc. - Common Stock are outstanding?
Intra-Cellular Therapies Inc. - Common Stock has 12B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.